IFNG and infection: Considering the key role of the JAK/STAT pathway in innate immunity, immune tolerance (22), cytokine cascade, and interferon gamma response (23), we can hypothesize that a spectrum of pralsetinib infections might be related to the off-target inhibition of the JAK/STAT pathway.